· AIM:Toevaluatethefunctionaloutcomeafterremoval ofsiliconeoil(ROSO)inpatientsundergoingretinectomy forcomplexretinaldetachment.
· RESULTS:Thirty-sixpatientswereincluded.Themean bestcorrectedvisualacuity (BCVA)pre-ROSOwas 1.13logMAR (SD0.5).ThemeanBCVA3mofollowing ROSOwas1.16logMAR(SD0.53),6mofollowingROSO 1.13(SD0.63),and12mofollowingROSO1.18(SD0.69). At12moafterROSO,theBCVAimprovedin38.9%of patients,remainedunchangedin25%,anddeteriorated in36.1%,althoughtherewasnostatisticalsignificant differenceinBCVAafterROSOat3,6and12mo( =0.93). Thesizeofretinectomyrangedfrom15毅 to270毅 (SD53) anddidnotinfluencethevisualoutcome( =0.11).
INTRODUCTION
A relaxingretinectomyisasurgicaltechniqueusually performedwhenstandardproceduresofretinal reattachmenthavefailed.Themainindicationsaresevere casesofproliferativevitreoretinopathy(PVR),advanced proliferativediabeticretinopathy (PDR)andpenetrating trauma [1] .Themainaimoftheprocedureistorelieveany tractionalforcesphysicallypreventingneurosensoryretinal contactwiththeretinalpigmentepithelium(RPE).A retinectomyusuallyinvolvestheuseofendodiathermyand siliconeoiltamponade whichcancauselongterm complicationssuchascataract,glaucomaandkeratopathy [2] . Previousstudieshaveidentifiedthatremovalofsiliconeoil (ROSO)isagoodindicatorforimprovedfinalvisualacuity (VA)inpatientsundergoingretinectomyforcomplexretinal detachments [3] .Forthesereasonsseveralauthorsrecommend ROSOassoonastheretinaappearsstable [4] [5] [6] . 
DISCUSSION
Siliconeoilhasbeenusedforcomplicatedretinal detachmentssincethe1960s [10] butlatecomplicationssuchas glaucoma,cataract [11] andkeratopathyarewellknown [2] and mostsurgeonssuggestitsremovalatsomepoint [6] . ManystudiesreportthatVAimprovesinthemajorityofeyes afterROSOhowevernotmanyhaveexclusivelyinvestigated theeffectofROSOfollowingaretinectomy [3, 6, [12] [13] [14] [15] .Similar studiesalsoeitherfailedtosegregatepatientswithsiliconeoil atthefinalfollow-upwhenreportingoutcomesorhad confoundingsurgicalfactorssuchas encirclingbands inserted [13] [14] 16] .Furthermore,notallstudiesreportedfollow-up durationsaslongasinthisstudy [17] .
Figure1Boxplot:pre-,post-ROSOBCVAtrendat3,6and 12mo. concluded thatgoodindicatorsforimprovedfinalVAwereshorter tamponadeduration,ROSO,smallerretinectomysize,and fewerpreviousoperations.BetterpreoperativeVAwasalso anindicatorforgoodoutcomesprobablybecausetheyare alsomarkersoflessadvancedPVR. ThestudiesfromLewis [18] andIverson [7] identified thatalargerretinectomyisassociatedwithaworsefinal visualoutcome.HoweverAlturki [19] andBovey [8] didnotfindanyassociationbetweentheextentof retinectomyandvisualoutcomes.Aswiththelatterstudies, wedidn'tfindthatalargerretinectomycorrelateswitha bettervisualprognosis. Inpreviousstudies,ROSOhadalsobeenassociatedwitha betterIOPcontrol [15] .Conversely,Flaxel [14] andFranks andLeaver [6] reportedthatonceglaucomahaddeveloped,it wasnotreversibleevenafterROSO.Inthisstudy,glaucoma wasdefinedasanIOPofmorethan25mmHgaccordingto Hutton [20] .Successofglaucomatreatmentisalsolower incaseswithsiliconeoil [21] [22] . Asthesizeofaretinectomyisnotrelatedtothefinal functionaloutcome,itwouldbeprudenttoensurethat intraoperatively,theextentoftheretinectomyisadequateto ensureretinalattachmentandoptimalanatomicalsuccess. Furthermore,ifthesurgicaloutcomeisfavourableatthe outset,thesurgeonwouldbeabletoconsiderremovalofthe siliconeoilattheearliestopportunitywithoutriskingaretinal redetachmentandavoidingsiliconeoil-relatedcomplications suchasglaucoma. Themainlimitationofthisstudywasitsretrospectivenature andassuch,itwasnotpossibletoensureaccurate documentationofthepre-operativePVRstatusforall patients.Furthermore,thedefinitionofglaucomadidnot includetheevaluationoftheopticnervestatus.The conversionofVAfromSnellentologMARcouldalsoresult ininaccuraciesastherelationshipsbetweenthetwomeasures arenotdirectlyproportional [23] [24] .
